|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 38/20 | |
| A61K 39/395 | |||
| A61P 35/00 | |||
| A61P 35/02 | |||
| G01N 33/574 |
| (11) | Patento numeris | 2435068 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 10781290.1 |
| Europos patento paraiškos padavimo data | 2010-05-28 | |
| (97) | Europos patento paraiškos paskelbimo data | 2012-04-04 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2015-03-04 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2010/036615 |
| Data | 2010-05-28 |
| (87) | Numeris | WO 2010/138839 |
| Data | 2010-12-02 |
| (30) | Numeris | Data | Šalis |
| 182081 P | 2009-05-28 | US |
| (72) |
TRIEU, Vuong, US
DESAI, Neil, US
KNAUER, Daniel, US
|
| (73) |
Abraxis BioScience, LLC,
11755 Wilshire Boulevard, Los Angeles, CA 90025,
US
|
| (54) | USE OF 2 ANTI-SPARC ANTIBODIES TO PREDICT RESPONSE TO CHEMOTHERAPY |
| USE OF 2 ANTI-SPARC ANTIBODIES TO PREDICT RESPONSE TO CHEMOTHERAPY |